Detalhe da pesquisa
1.
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.
J Transl Med
; 13: 139, 2015 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25933939
2.
Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial.
Clin Cancer Res
; 25(17): 5231-5241, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171545
3.
A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.
Blood Transfus
; 13(3): 464-71, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25761309
4.
Inhibition of herpesvirus-induced HIV-1 replication by cyclopentenone prostaglandins: role of IkappaB kinase (IKK).
AIDS
; 18(9): 1271-80, 2004 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-15362659
5.
IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.
Immunobiology
; 216(5): 537-47, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21093097
6.
IFN-alpha promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment.
Blood
; 103(3): 980-7, 2004 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14525781